AI Wiki

Explore AI Wiki

Corrections

When we get something substantively wrong, we fix it and log the fix here; small copyedits live in each article's revision history instead. Found an error? Use the "Report issue" button on the article (no account needed). So far we have received 2 reports and reviewed 1, taking a median of 4.8 days. 1 is waiting, the oldest since September 26, 2026. That is our record rather than a promise. See the verifiability policy for how checking works.

321 articles were corrected in the last 30 days. Every correction note and resolved report is listed below, newest first. A fix applied to several articles with the same note is shown once, listing each article; "See the change" opens that version in the article's revision history.

  1. editorial

    CME compute futures no longer on track for October 5 (CFTC review extended to November 9, 2026; effective date TBD); Nodal/Compute Desk announced September 3, not 4

  2. editorial

    Axios ref author was Emily Peck, not Scott Rosenberg; CME product page no longer gives Oct 5 (now 'later this year'); Bandi-Su paper dated July 2026 (v3 Sep 10), not an August paper; unsupported intended-use wording fixed; dead SER PDF link replaced. Update: CFTC extended review to Nov 9, 2026 (Sep 21 letter), register 'Approval Pending (90)', CME Clearing lists launch date TBD (Sep 25); CFTC request for comment (Aug 19, 91 FR 54259, comments due Oct 20); fees, hours, Silicon Data index changes; competing venues table (ICE-Ornn, ICE-NATIVX, Nodal-Compute Desk, OneChronos, Architect AX) with link to Ornn.

  3. editorial

    Ornn publishes indices rather than running an exchange; ICE release date; settlement-series caveat (verifier V2)

  4. editorial

    Sep 2028 projection totals include all rent since purchase, not two years; Seoul Economic Daily figure flagged as irreconcilable with Ornn public series; Ali Yahya paraphrase not quote; cross-link wording (verifier V2)

  5. editorial

    IMO 2024 Problem 6 was algebra, not number theory; GNoME 380,000 (not 381,000) most-stable materials, 736 syntheses were concurrent (not subsequent), unsourced 45x claim removed; AlphaFold2 '2 million' figure is people using AlphaFold2 (not database researchers); AlphaFold2 trained on TPU v3, not GPUs; DeepMind-CFS partnership announced Oct 2025 (not 2024); BCG Phase I/II figures corrected; unsourced Nobel 'first time' and ChatGPT claims removed; dead Drug Target Review ref replaced; miscited refs (WeatherNext 2, DIII-D, AI for Math, challenges) fixed; co-scientist credited to Google Research/DeepMind/Cloud AI. Update: new section on agentic AI scientists 2024-2026 (Sakana AI Scientist, Google Co-Scientist Nature paper and Gemini for Science, FutureHouse Robin/Kosmos, OpenAI for Science, Anthropic Claude Science and ART discovery), Genesis Mission, Chai-2, FDA AIM-NASH.

  6. editorial

    Attribute conflicting Suncatcher prototype lifetime reports (Ars Technica: a few months; Space.com citing NYT: a year); update launch status to September 28, 2026

  7. editorial

    No proposal form on the post; the reverse transcriptase itself was already known; TNW author added (verifier V1)

  8. editorial

    Benchmark bin figures, causal overstatement of the 39% file-reading result, selection timing of the two interpretability signals, upstream-DNA detail, genomic vision wording, Bo Wang attribution, and minor framing fixes (verifier V1)

  9. editorial

    Launch-day user table misstated Manifold Bio (it nominated targets, not medicine candidates) and Lecoq (about 10 reviews, not 10-plus); Amodei paraphrase 'only with their minds' was presented as a quote; unsupported claims removed (Claude Code GA/$2.5B revenue, $47B/$9B revenue, Series H, IPO 'at ~$965B' (Yahoo says last valued at $965B), Jumper role, Synthetic Sciences $1.9M raise); Modal credits are for select projects, not per project; Novo Nordisk/Allen Institute sourced to TechCrunch; GPT-Rosalind announced April 16 not 17; HN ref pointed to a different 'Open Science' project; Drake quote and cost wording fixed; '4x' skill claim attributed to 36Kr. Update: Windows version (Sep 10, 2026), still beta; Claude Team plan for scientists and expanded AI for Science program (Aug 27); models and safeguards incl. LSVP and Opus 5.5; GPT-Rosalind out of preview Sep 11; new Notable uses section (protein design, analytical chemistry, FlashPairformer optimization, ART).

  10. editorial

    Opus 5.5 was deployed with safeguards 'similar to' (not 'the same as') Fable 5.1's and the 'impeded' wording was unsupported; Benchling press release was Oct 20, 2025 (not the Coefficient Bio deal day); wet-lab quote now verbatim from Reuters; Proteinbase quotes now match '$1 million+'. Update: Sep 2026 research group and lab (BSL-1/2, human-run), ART reverse-transcriptase discovery, call for proposals, competition tracks, Reuters robotics reporting, Novo Nordisk collaboration.

  11. editorial

    Verification fix (TIME story was published on launch day)

  12. editorial

    Verification fix (S-4 gives ~$1.985B post-money at the June 2025 Series C-3)

  13. editorial

    Verification fix (5.2 m/s is about 11.6 mph)

  14. editorial

    Verification fixes (speed citation, order citation)

  15. editorial

    Verification fix (50 percent figure is ETH News wording)

  16. editorial

    Verification fixes (Boston Dynamics stake status attributed; SoftBank ownership dates)

  17. editorial

    SoftBank agreed to buy Boston Dynamics in June 2017 and completed the purchase in February 2018; RAI Institute's Spot ran at a sustained 5.2 m/s (not 'exceeding'), sourced to IEEE Spectrum and the RAI partnership release rather than the NVIDIA blog

  18. editorial

    IPO gross proceeds were HK$1,015.38 million (HK$905.87 million estimated net), not HK$914 million; 1,000th Walker S2 rolled off in December 2025; Walker X specs corrected to UBTECH's spec sheet (no 145 cm/77 kg/10 km/h sprint); S1 41-DOF and 0.83 m/s figures attributed to third-party spec listings

  19. editorial

    1,000th Walker S2 rolled off the Liuzhou line in December 2025 (not early January 2026); 2025 orders were 'nearly' RMB1.4 billion (21st Century Business Herald), not 'exceeded', and the cited source did not contain the figure; Walker X specs corrected to UBTECH's spec sheet (130 cm, 63 kg, no 10 km/h sprint) and shown in July 2021; Audi FAW leak-detection row sourced

  20. editorial

    The 150 million figure is RAI Institute's 'about 150 million runs of the simulator' for one Atlas motion-capture policy, not 'per maneuver', and it is not in the cited Boston Dynamics Spot post (which reports over a million simulations and an Isaac Lab-based Spot environment)

  21. editorial

    Robert Playter announced his departure as CEO in February 2026 (CFO Amanda McMaster interim CEO); the RAI Institute partnership release describes a shared reinforcement learning training pipeline, not a fully shared simulation, training and evaluation stack

  22. editorial

    SoftBank agreed to buy Boston Dynamics in June 2017 but completed the acquisition in February 2018; current Boston Dynamics chairman title unverified (2026 company release calls him founder); added Hyundai's decision to sell its RAI Institute stake and the reported SoftBank purchase

  23. editorial

    Boston Dynamics stake is no longer 80 percent (90.35 percent by July 2026 per Yonhap, SoftBank's remaining 9.65 percent being bought out); RMAC was announced for 2026 at CES, began pilot operations in June 2026 and was launched on 21 Sep 2026; Playter's 2026 departure noted

  24. editorial

    The 25,000-unit Atlas deployment plan is sourced (Hyundai Motor Group JPMorgan investor session, May 2026; Boston Dynamics RMAC release, 21 Sep 2026); it is a plan, not an installed base

  25. editorial

    Height and weight per Figure's product page (5 ft 8 in, 61 kg; TIME reported 5-foot-6), remove unsourced sub-$20,000 price target, attribute 90% component-cost figure to TIME, remove Helix Lab claim sourced only to an AI-generated news page